Aquestive Therapeutics (AQST) EBIT Margin Growth (1y) (2018 - 2026)
Aquestive Therapeutics (AQST) EBIT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 304.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -157.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,330.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -650.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 8,630.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1,962.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 111.00 |
| 10 | Aquestive Therapeutics | 462.24 Mn | 462.24 Mn | 13.47 Mn | 19,297.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19,297.00 |
| Dec 31, 2025 | 20,870.00 |
| Sep 30, 2025 | -2,841.00 |
| Jun 30, 2025 | -11,392.00 |
| Mar 31, 2025 | -14,776.00 |
| Dec 31, 2024 | -8,481.00 |
| Sep 30, 2024 | -4,294.00 |
| Jun 30, 2024 | 3,206.00 |
| Mar 31, 2024 | -3,295.00 |
| Dec 31, 2023 | 7,067.00 |
| Sep 30, 2023 | 5,895.00 |
| Jun 30, 2023 | 12,774.00 |
| Mar 31, 2023 | 3,800.00 |
| Dec 31, 2022 | 504.00 |
| Sep 30, 2022 | -1,726.00 |
| Jun 30, 2022 | 16,632.00 |
| Mar 31, 2022 | 2,720.00 |
| Dec 31, 2021 | 9,024.00 |
| Sep 30, 2021 | 11,229.00 |
| Jun 30, 2021 | -33,079.00 |